Status:

COMPLETED

Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection

Lead Sponsor:

Sun Yat-sen University

Conditions:

Diagnosis

Diabetic Retinopathy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

With the increase in population and the rising prevalence of various diseases, the workload of disease diagnosis has sharply increased. The accessibility of healthcare services and long waiting times ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria The study will include adults aged 18 years and above who have been diagnosed with Type 2 diabetes but have not previously been screened for DR. Participants must demonstrate good compliance with clinical examinations, and provide informed consent.
  • Exclusion criteria The study will exclude patients who have previously been diagnosed with DR, those who have recently undergone eye surgery, and those with other significant eye diseases that could potentially confound the results of DR screening. Individuals with ocular, auditory, or cognitive impairments that prevent the use of mobile phones or reading will also be excluded.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 30 2023

    Estimated Enrollment :

    535 Patients enrolled

    Trial Details

    Trial ID

    NCT05231174

    Start Date

    May 1 2023

    End Date

    July 30 2023

    Last Update

    January 19 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Zhognshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong, China, 510000